Vardenafil 2.5 mg: why the small start exists

012.5 mg is printed for a reason

Two point five milligrams is printed on Levitra because some charts cannot tolerate ordinary milligrams. Clip that reason, cross the QT and CYP lists, then file.

The usual labelled start remains 10 mg as needed, once daily at most, then move to 20 mg or down to 5 mg. The 2.5 mg orange tablet is not a marketing teaser. It is the labeled small start when strong or moderate CYP3A4 inhibitors, or certain alpha-blocker plus inhibitor pairings, would otherwise multiply exposure. Halo Medix locks this brief on that tablet because search pages treat 2.5 mg as a shy first buy. The label treats it as a safety strength.

Clip the imprint. Levitra film-coated tablets come in 2.5, 5, 10, and 20 mg. Staxyn is a 10 mg orally disintegrating tablet and is not interchangeable with a 10 mg film-coated swallow. Do not dissolve a 2.5 mg film tablet and call it Staxyn. Do not assume four 2.5 mg tablets equal a labeled 10 mg ODT exposure.

Cross two lists before the first 2.5. One: nitrates, nitrites, and riociguat - absolute stops. Two: congenital long QT, quinidine, procainamide, amiodarone, sotalol - avoid vardenafil. A man can be 'only 2.5 mg' and still be in the wrong drug class if the ECG story is dirty.

Lens from Montreal: if the chart is clean and the man is not on a CYP3A4 inhibitor, 2.5 mg is often under-dosing dressed up as caution. If ritonavir or ketoconazole 400 mg daily is on the list, 2.5 mg is the entire allowed story for a day or a 72-hour window. Know which of those two patients you are filing.

02QT footnote before the first swallow

Class IA and class III antiarrhythmics are avoid-use settings for vardenafil, as is congenital QT prolongation. Quinidine and procainamide sit in the first group. Amiodarone and sotalol sit in the second. The 2.5 mg tablet does not cancel that footnote. A smaller peak is still a vardenafil peak.

A thorough QT study in 59 healthy men compared therapeutic 10 mg and supratherapeutic 80 mg vardenafil with moxifloxacin 400 mg. Both vardenafil doses and the active control produced similar QTc increases. The 80 mg dose was chosen because it covers concentrations seen when low-dose vardenafil meets ritonavir 600 mg twice daily. A later study of vardenafil plus another QT-active drug showed an additive effect.

That is why this card asks the ECG question before anyone celebrates a cheap 2.5 mg fill. Men on sotalol for atrial fibrillation are not 'almost fine' at 2.5 mg. They are in the avoid group. See the QT screen note before the contrast sheet argument about onset speed.

Moxifloxacin in that study is a reminder that 'small QTc change' is not the same as 'safe to stack with another QT drug.' Additive effects are how outpatient cocktails become telemetry stories. If the medication list already prolongs QT, pick a different ED path rather than shrinking Levitra and hoping.

03Ritonavir is why this tablet exists

Ritonavir multiplied vardenafil AUC forty-nine-fold and Cmax thirteen-fold when 600 mg twice daily met a 5 mg vardenafil tablet. Half-life stretched to about 26 hours. The labeled cap is a single 2.5 mg tablet no more often than every 72 hours. That sentence is the entire justification for keeping 2.5 mg in the warehouse.

Cobicistat follows the same 2.5 mg per 72-hour cap. Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, and clarithromycin cap vardenafil at 2.5 mg in a 24-hour period. Ketoconazole 200 mg daily is a 5 mg per 24-hour cap in the interaction section. Erythromycin, a moderate inhibitor, has its own 5 mg cap. Do not flatten all of that into 'just use 2.5 forever' without reading which inhibitor is actually on the blister.

Indinavir with 10 mg vardenafil raised AUC 16-fold and Cmax 7-fold and doubled half-life. Again the labeled answer is 2.5 mg in 24 hours, not a hopeful half of a 10 mg tablet. Film-coated orange tablets are not a titration kit.

If none of those inhibitors is present, insisting on 2.5 mg as a universal first dose is not conservative. It is often ineffective, which then produces a second tablet the same night. The usual labeled start remains 10 mg. Age 65 and older is a 5 mg consideration because Cmax and AUC ran 34 and 52 percent higher than in younger men - still not automatically 2.5 mg.

04Child-Pugh B stays at a smaller start

Generic vardenafil 2.5 mg, eight tablets, the Halo small-start lock, August 2026. GoodRx Levitra table lists 2.5 mg x 30 at $1,100.46 average retail and $289.61 with a coupon. Staxyn 10 mg ODT is a different fill. Halo does not dispense.

Child-Pugh B starts at five milligrams, with a maximum of 10 mg. After a 10 mg dose in moderate hepatic impairment, Cmax rose 130 percent and AUC 160 percent versus controls. Child-Pugh C is a do-not-use. Child-Pugh A had smaller rises (Cmax +22 percent, AUC +17 percent) and no routine adjustment.

Severe hepatic impairment is not a 2.5 mg kindness. The label's language is do not use, because the drug was not evaluated there. Shrinking the tablet does not create a study that never ran.

Elderly men had higher exposure, which is why 5 mg is the age-related consideration, not 2.5 mg by default. Phase 3 still included hundreds of men 65 and older at 5, 10, and 20 mg without a unique safety signal versus younger men. Exposure, not birthday cake, drives the start.

Renal dosing details live on the full label. The interaction that should scare a Montreal HIV clinic more than a creatinine of 55 is still ritonavir plus an ordinary 10 mg Levitra. File the 2.5 mg tablet for that pairing, not as a universal geriatric gesture.

05Alpha-blocker overlap after a stable week

Initiate vardenafil only after alpha-blocker therapy is stable, and start at the lowest recommended dose. For many charts that lowest film-coated start is 5 mg. It becomes 2.5 mg when certain CYP3A4 inhibitors are also present. Simultaneous Tmax of vardenafil and terazosin produced standing systolic pressures under 85 mm Hg often enough that one study arm stopped early.

Tamsulosin 0.4 mg plus vardenafil still produced outlier standing drops in a healthy-volunteer design. Symptoms of hypotension caused withdrawals. The 2.5 mg tablet is not a free pass to start both drugs on the same night. Sequence them.

If the man is already on a stable alpha-blocker and a strong CYP3A4 inhibitor, 2.5 mg is doing two jobs at once: interaction cap and hypotensive caution. Write both reasons in the chart so the next clinician does not 'correct' the dose up to 10 mg because 2.5 looks timid.

06Fasted peak near an hour if the plate is not greasy

Fasted peak sits near sixty minutes. The range is 30 minutes to two hours after a single 20 mg dose in healthy men. Absolute bioavailability is about 15 percent. Terminal half-life of vardenafil and its primary metabolite M1 is about 4 to 5 hours. Clearance is about 56 L/h. Metabolites leave mainly in feces (about 91 to 95 percent) and little in urine (about 2 to 6 percent).

Two food-effect studies showed high-fat meals cut Cmax by 18 to 50 percent. The film-coated tablet may still be taken with or without food. A greasy plate is why a man says 2.5 mg 'does nothing' when the real problem is a delayed, blunted peak on a night he also expected 10 mg performance from a safety tablet.

Onset notes belong at vardenafil onset. The useful clinic line: empty-enough stomach, stimulation present, one tablet in 24 hours unless a CYP rule stretches the interval to 72 hours. Do not chase a greasy dinner with a second 2.5 mg.

Compare the short clock with sildenafil 100 mg (also about a four-hour half-life, heavier food hit on Cmax) and daily tadalafil 2.5 mg (17.5-hour half-life, food neutral) on the contrast sheet. Speed is not safety.

07Staxyn is not a smaller Levitra

Staxyn orally disintegrating tablets are a 10 mg vardenafil product with higher systemic exposure than a 10 mg film-coated Levitra tablet. The labels say they are not interchangeable. A man who 'does not like pills' cannot be moved to Staxyn as if it were a 10 mg cousin, and he cannot be moved to four 2.5 mg film tablets as if that rebuilt Staxyn.

Staxyn has its own CYP3A4 rule: do not use it with potent or moderate CYP3A4 inhibitors. When those inhibitors are present, the film-coated 2.5 mg tablet is the product the vardenafil label still knows how to dose. Substituting ODT because a shelf is empty is an exposure error.

Place Staxyn on the tongue and let it disintegrate. Do not swallow it whole like Levitra and do not chase it with a second film tablet because 'it felt light.' If a clinic wants the 2.5 mg lock on this card, that is a film-coated conversation, not an ODT conversation.

Phenylalanine appears in some vardenafil tablet formulations that use aspartame. The 2.5 mg tablet in one U.S. listing carries 0.7 mg phenylalanine. In phenylketonuria, add that amount to the rest of the day's aspartame load. It is a small number and still a real one for the right patient.

08Selectivity does not cancel class hypotension

Stops and caps that outrank 'small tablet' talk

• Nitrates / NO donors: contraindicated; no labeled safe interval
• Riociguat: contraindicated
• Congenital long QT or Class IA/III antiarrhythmics: avoid
• Ritonavir / cobicistat: 2.5 mg / 72 h, not a casual 10 mg

Higher PDE5 selectivity does not cancel nitrate math. Organic nitrates and nitric oxide donors in any form are contraindicated. A suitable time interval after vardenafil for safe nitrate use has not been determined. Riociguat is contraindicated as a GC stimulator. The 2.5 mg lock does not create a loophole.

Selectivity talk is how some pages claim Levitra is 'cleaner' than Viagra. The useful difference on this card is the QT footnote and the extreme ritonavir interaction, not a moral ranking of enzymes. Flushing, headache, and rhinitis still happen. Discontinuation for adverse events in pooled vardenafil work was 1.9 percent versus 0.8 percent on placebo.

Priapism beyond four hours is an emergency. Sudden vision or hearing loss is a stop-and-seek-care rule, same class as the other two oral PDE5 inhibitors. Do not tell a man that 2.5 mg is too small to matter for those warnings.

Unstable patients told not to have sex should not take vardenafil at any listed strength. Stable coronary disease without nitrates is a cardiology-cleared maybe, not a green light from a 2.5 mg imprint.

09File the small-start card after the ECG question

Close the 2.5 mg card after you know why that strength was chosen. Clean chart, no inhibitor: 10 mg is still the usual labeled start. Ritonavir or cobicistat: 2.5 mg every 72 hours. Other named strong inhibitors: 2.5 mg in 24 hours. Long QT or class IA/III drugs: do not use vardenafil at any listed milligram.

Staxyn is not a smaller Levitra. High-fat meals can cut Cmax by up to half. Nitrates and riociguat close every PDE5 file, including this one. Sudden vision, hearing loss, or a four-hour erection is emergency care.

Ask a licensed clinician before starting or combining this tablet. Educational mail: [email protected]. Reviewer: Dr. Camille Rousseau, MD, Montreal.